Diagnosis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis led by sarcoplasmic myxovirus resistance protein A expression on muscle pathology-Reference-Cited by-同舟云学术

Diagnosis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis led by sarcoplasmic myxovirus resistance protein A expression on muscle pathology

Published:2024 Issue:7 Volume:64 Page:480-485
ISSN:0009-918X
Container-title:Rinsho Shinkeigaku
language:en
Short-container-title:Rinsho Shinkeigaku

Author:

Iwami Kosuke¹,Kano Takahiro¹,Mizushima Keiichi²,Yaguchi Hiroaki²,Nishino Ichizo³,Houzen Hideki¹

Affiliation:

1. Department of Neurology, Obihiro Kosei General Hospital

2. Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University

3. Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)

Publisher

Societas Neurologica Japonica

Link

https://www.jstage.jst.go.jp/article/clinicalneurol/64/7/64_cn-001963/_pdf

Reference28 articles.

1. 1) Mammen AL, Allenbach Y, Stenzel W, et al. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. Neuromuscul Disord 2020;30:70-92.

2. 2) Uruha A, Nishikawa A, Tsuburaya RS, et al. Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology 2017;88:493-500.

3. 3) Uruha A, Allenbach Y, Charuel JL, et al. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathol Appl Neurobiol 2019;45:513-522.

4. 4) Allenbach Y, Uzunhan Y, Toquet S, et al. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody. Neurology 2020;95:e70-78.

5. 5) Nombel A, Fabien N, Coutant F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol 2021;12:773352.